Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Rani Therapeutics Holdings Inc
RANICurrent price
2.35 USD
-0.07 USD (-2.89%)
Last closed
2.57 USD
Company
www.ranitherapeutics.com
ISIN
US7530181004
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
139 460 928 USD
Yield for 12 month
+18.09 %
1Y
3Y
5Y
10Y
15Y
RANI
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California. Address: 2051 Ringwood Avenue, San Jose, CA, United States, 95131
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.75 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-822 000 USD
Last Year
-1 312 000 USD
Current Quarter
-255 000 USD
Last Quarter
-248 000 USD
Key Figures RANI
1 year
3 years
5 years
10 years
EBITDA
-56 898 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-56.83 %
PEG Ratio
–
Return On Equity TTM
-225.35 %
Wall Street Target Price
11.75 USD
Revenue TTM
–
Book Value
0.11 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
2 717 000 USD
Earnings per share
-1.18 USD
Diluted Eps TTM
-1.18 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RANI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RANI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RANI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
84.2765
Price Sales TTM
313.1706
Enterprise Value EBITDA
-1.4229
Price Book MRQ
27.6189
Financials RANI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RANI
For 52 weeks
1.9 USD
8.75 USD
50 Day MA
2.42 USD
Shares Short Prior Month
788 592
200 Day MA
3.66 USD
Short Ratio
0.73
Shares Short
2 548 518
Short Percent
15.61 %
BeatStart